title: Incidence of acute oral sequelae in pediatric patients undergoing chemotherapy.
abstract: OBJECTIVE
  The purpose of this literature review was to assess the incidence of acute oral sequelae in children receiving cytotoxic therapy.
  
  
  METHODS
  The dental literature was searched using 3 electronic databases--Cochrane, Medline, and Embase--from 1966 to 2006 and was limited to articles reporting acute oral sequelae in patients receiving chemotherapy with or without radiotherapy and to individuals younger than 20 years old.
  
  
  RESULTS
  Nineteen articles fulfilled the inclusion criteria and were included in this review. The overall incidence of acute oral sequelae in children was 54%. The incidence of oral sequelae was higher in children who received myeloablative therapy prior to bone marrow transplantation compared to those who received only chemotherapy with or without radiotherapy.
  
  
  CONCLUSIONS
  The lock of consensus on what constitutes acute oral sequelae and on universally accepted assessment tools complicates the determination of incidence. Acute oral sequelae are frequent in children and the incidence appears to be comparable to adults.
authors: Pediatric Dentistry, Department of Oral Medicine, Carolinas Medical Center, Charlotte, NC, USA. Catherine.Hong@carolinashealthcare.org
authors: C H
authors: CH
authors: Hong
authors: M T
authors: MT
authors: Brennan
authors: P B
authors: PB
authors: Lockhart
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D009059:Mouth Diseases / Q000139:chemically induced*; D019653:Myeloablative Agonists / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D019653:Myeloablative Agonists